mobiquity_technoliges_logo.jpg
Mobiquity Technologies and ElecTech: AI-Driven Successes in Primary Elections
July 10, 2023 08:30 ET | Mobiquity Technologies, Inc.
NEW YORK, July 10, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions,...
mobiquity_technoliges_logo.jpg
Mobiquity Technologies Enhances ElecTech and ElecAlytics A.I. Platforms to Create More Personalized Audience Connections
July 05, 2023 08:00 ET | Mobiquity Technologies, Inc.
NEW YORK, July 05, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions,...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Successfully Manufactures Clinical Supply – Initiation of Pediatric Phase 3 Studies to Commence in July and August
June 29, 2023 08:00 ET | Cingulate Inc.
KANSAS CITY, Kan., June 29, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Completes Phase 3 Adult Trial of CTx-1301 (dexmethylphenidate) for ADHD
June 08, 2023 07:00 ET | Cingulate Inc.
Study Assessed Onset and Duration of CTx-1301 in Adults, Results Expected 3Q 2023 Pivotal Phase 3 Trials in Pediatric/Adolescent Patients on Schedule for 3Q 2023 Initiation KANSAS CITY, Kan., June ...
mobiquity_technoliges_logo.jpg
Mobiquity Technologies Launches ElecAlytics, an AI-Powered Analytics Suite Added to Its ElecTech Platform for Political Campaigns
June 07, 2023 08:00 ET | Mobiquity Technologies, Inc.
NEW YORK, June 07, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions,...
Cingulate_Logo_400x400_twitter.jpg
Cingulate to Present at 13th Annual LD Micro Invitational
May 25, 2023 15:55 ET | Cingulate Inc.
KANSAS CITY, Kan., May 25, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
mobiquity_technoliges_logo.jpg
Mobiquity Technologies Launches ElecTech, an AI Powered Programmatic Advertising Solution for Political Campaigns
May 18, 2023 08:00 ET | Mobiquity Technologies, Inc.
NEW YORK, May 18, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions,...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Inc. Reports First Quarter 2023 Financial Results and Provides Clinical and Business Update
May 10, 2023 16:15 ET | Cingulate Inc.
Additional $3 Million of Financing Proprietary PTR™ Manufacturing Processes Successfully Transferred to Societal CDMO Joint Commercialization Agreement for Lead ADHD Candidate CTx-1301 KANSAS...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Announces Successful Transfer of CTx-1301 (dexmethylphenidate) Proprietary PTR™ Manufacturing Processes to Societal CDMO
May 03, 2023 06:45 ET | Cingulate Inc.
KANSAS CITY, Kan., May 03, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
mobiquity_technoliges_logo.jpg
Mobiquity Technologies’ AI Targeting Gains Traction with Political Advertisers as Election Season Kicks Off
April 26, 2023 08:00 ET | Mobiquity Technologies, Inc.
NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology...